Wearables such as smartwatches are already an integral part of our everyday lives. They track our pulse, the number of steps we take and our sleep rhythm. Glucose measurement using CGM systems is currently considered the gold standard. Can Dincer, Professor of Sensors and Wearables for Healthcare at the Technical University of Munich (TUM), explains in an interview in which direction the development can still go in the future.
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis
Implement the “minimal disease activity” concept
- Sensation of pain
Special features for people with multiple disabilities
- Atopic dermatitis
Clinic, therapy and prevention in early childhood
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- COPD exacerbations